Nutriband Inc. (NASDAQ:NTRBW) Short Interest Update

Nutriband Inc. (NASDAQ:NTRBW) was the recipient of a large growth in short interest in the month of August. As of August 31st, there was short interest totaling 1,746 shares, a growth of 9,600.0% from the August 15th total of 18 shares. Based on an average daily trading volume, of 10,970 shares, the short-interest ratio is currently 0.2 days.

Institutional Investors Weigh In On Nutriband

A hedge fund recently bought a new position in Nutriband stock. Empery Asset Management LP acquired a new stake in Nutriband Inc. (NASDAQ:NTRBW) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 40,218 shares of the company’s stock, valued at approximately $65,000. Nutriband makes up about 0.1% of Empery Asset Management LP’s portfolio, making the stock its 20th biggest holding.

Nutriband Stock Performance

NTRBW traded up $0.19 during trading on Thursday, reaching $0.39. The company had a trading volume of 7,206 shares, compared to its average volume of 3,863. Nutriband has a 12 month low of $0.17 and a 12 month high of $2.99. The business’s fifty day moving average price is $0.55 and its 200 day moving average price is $0.98.

About Nutriband

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.